<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.11.81 (http://www.squarespace.com/) on Thu, 31 May 2012 16:07:51 GMT--><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0"><channel><title>Press/Media</title><link>http://www.eyesthetica.com/press/</link><description></description><lastBuildDate>Fri, 18 Feb 2011 20:49:39 +0000</lastBuildDate><copyright></copyright><language>en-US</language><generator>Squarespace Site Server v5.11.81 (http://www.squarespace.com/)</generator><item><title>Media #1</title><dc:creator>Eyesthetica</dc:creator><pubDate>Fri, 04 Feb 2011 20:48:00 +0000</pubDate><link>http://www.eyesthetica.com/press/2011/2/4/media-1.html</link><guid isPermaLink="false">807911:9484071:10525223</guid><description><![CDATA[<p>embedded video</p>]]></description><wfw:commentRss>http://www.eyesthetica.com/press/rss-comments-entry-10525223.xml</wfw:commentRss></item><item><title>Press/Article #1</title><dc:creator>Eyesthetica</dc:creator><pubDate>Fri, 04 Feb 2011 20:47:00 +0000</pubDate><link>http://www.eyesthetica.com/press/2011/2/4/pressarticle-1.html</link><guid isPermaLink="false">807911:9484071:10525204</guid><description><![CDATA[<p>excerpt and link.</p>]]></description><wfw:commentRss>http://www.eyesthetica.com/press/rss-comments-entry-10525204.xml</wfw:commentRss></item></channel></rss>
